Zhao J X, Yang L P, Wang Y F, Qin L P, Liu D Q, Bai C X, Nan X, Shi S S, Pei X J
Stem cell [corrected] and Regenerative Medicine Lab [corrected], Beijing Institute of Transfusion Medicine, [corrected] Beijing, China.
Eur J Neurol. 2007 May;14(5):510-6. doi: 10.1111/j.1468-1331.2006.01705.x.
The matrix metalloproteinases (MMPs) have come to be highlighted by their close relation to the cell invasion of gliomas. The inhibitors of MMPs have undergone extensive development because of its effectiveness against tumor invasion and angiogenesis. Therefore, a suitable animal model is necessary for searching new MMPs inhibitors against gliomas. In this study, we established an experimental model by implanting 9L glioma cells stereotactically into Fisher344 (F344) rat's brain, and the expression and enzymatic activity of MMP-2 and MMP-9 in 9L glioma cells and in tumor tissue was determined by means of reverse transcription polymerase chain reaction (RT-PCR), sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) zymography, in situ film zymography and immunostaining. The results of RT-PCR showed that the mRNA level of MMP-2 in 9L glioma cells was higher than that of MMP-9, and the mRNA expression of MMP-9 was increased along with the growth of malignant gliomas. SDS-PAGE zymography revealed that the expression of MMP-2 and MMP-9 were significantly increased in tumor tissues, and the MMP-9 wasn't detected in normal tissue. The positive stain of MMP-2 and MMP-9 was enhanced with the growth of malignant gliomas, especially for MMP-9. The expression of active gelatinase was found in tumor tissue. In conclusion, the expression of active MMP-2 and MMP-9 was increased in 9L/F344 rat brain during the growth of malignant gliomas at different time intervals, which indicate that 9L/F344 animal model may be a prospective animal model to test new MMPs inhibitors.
基质金属蛋白酶(MMPs)因其与胶质瘤细胞侵袭的密切关系而受到关注。由于MMPs抑制剂对肿瘤侵袭和血管生成具有有效性,因此其得到了广泛的研发。因此,需要一种合适的动物模型来寻找针对胶质瘤的新型MMPs抑制剂。在本研究中,我们通过将9L胶质瘤细胞立体定向植入Fisher344(F344)大鼠脑内建立了一个实验模型,并通过逆转录聚合酶链反应(RT-PCR)、十二烷基硫酸钠聚丙烯酰胺凝胶电泳(SDS-PAGE)酶谱分析、原位膜酶谱分析和免疫染色来测定9L胶质瘤细胞和肿瘤组织中MMP-2和MMP-9的表达及酶活性。RT-PCR结果显示,9L胶质瘤细胞中MMP-2的mRNA水平高于MMP-9,且MMP-9的mRNA表达随恶性胶质瘤的生长而增加。SDS-PAGE酶谱分析表明,肿瘤组织中MMP-2和MMP-9的表达显著增加,而正常组织中未检测到MMP-9。随着恶性胶质瘤的生长,MMP-2和MMP-9的阳性染色增强,尤其是MMP-9。在肿瘤组织中发现了活性明胶酶的表达。总之,在不同时间间隔的恶性胶质瘤生长过程中,9L/F344大鼠脑内活性MMP-2和MMP-9的表达增加,这表明9L/F344动物模型可能是一种用于测试新型MMPs抑制剂的有前景的动物模型。